Contracts total
684 168 €
Bids
2
Type
Supplies
Published
29.12.2025
Tender description
Ravimite ostmine vastavalt RHAD lisas I Tehniline kirjeldus-pakkumuse vorm kirjeldatule. / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest
Awarded contracts
17.03.2026| Lot | Tenderer | Amount | Bids | Awarded |
|---|---|---|---|---|
| Gadoteerhape | First Pharma OÜ | 13 655 € | 1 | 16.03.2026 |
| Ipilimumab | TAMRO EESTI OÜ | 201 347 € | 1 | 12.03.2026 |
| Filgrastiim | TAMRO EESTI OÜ | 11 132 € | 1 | 12.03.2026 |
| Kabasitakseel | MAGNUM MEDICAL OÜ | 5696 € | 2 | 13.03.2026 |
| Tsisplatiin | MAGNUM MEDICAL OÜ | 13 050 € | 1 | 13.03.2026 |
| Etoposiid | Apteegikaubanduse Hulgimüük OÜ | 7578 € | 1 | 11.03.2026 |
| Avelumab | MAGNUM MEDICAL OÜ | 55 080 € | 2 | 13.03.2026 |
| Vedolizumab | TAMRO EESTI OÜ | 115 275 € | 1 | 12.03.2026 |
| Risankizumab süstelahus | MAGNUM MEDICAL OÜ | 110 184 € | 1 | 13.03.2026 |
| Risankizumab infusioonilahus | MAGNUM MEDICAL OÜ | 55 092 € | 1 | 13.03.2026 |
| Anifrolumab | MAGNUM MEDICAL OÜ | 32 256 € | 1 | 13.03.2026 |
| Belimumab | TAMRO EESTI OÜ | 13 838 € | 1 | 12.03.2026 |
| Guselkumab pensüstel 100mg | TAMRO EESTI OÜ | 16 663 € | 2 | 12.03.2026 |
| Guselkumab pensüstel 200mg | TAMRO EESTI OÜ | 16 663 € | 2 | 12.03.2026 |
| Guselkumab, infusioonilahuse kontsentraat | TAMRO EESTI OÜ | 16 663 € | 2 | 12.03.2026 |
Tender lots
20| Lot | Estimated value | Deadline |
|---|---|---|
| Hanke osa 1 on eemaldatud! Palonosetroon + netupitant | 7000 € | 11.02.2026 |
| Hanke osa 2 on eemaldatud! Humaanfibrinogeen | 39 000 € | 11.02.2026 |
| Triamtsinoloon | 5000 € | 11.02.2026 |
| Gadoteerhape | 15 000 € | 11.02.2026 |
| Okrelizumab | 95 000 € | 11.02.2026 |
| Ipilimumab | 230 000 € | 11.02.2026 |
| Filgrastiim | 90 000 € | 11.02.2026 |
| Remimasolaam | 5000 € | 11.02.2026 |
| Kabasitakseel | 15 000 € | 11.02.2026 |
| Tsisplatiin | 18 000 € | 11.02.2026 |
| Etoposiid | 10 000 € | 11.02.2026 |
| Avelumab | 65 000 € | 11.02.2026 |
| Vedolizumab | 125 000 € | 11.02.2026 |
| Risankizumab süstelahus | 120 000 € | 11.02.2026 |
| Risankizumab infusioonilahus | 70 000 € | 11.02.2026 |
| Anifrolumab | 40 000 € | 11.02.2026 |
| Belimumab | 30 000 € | 11.02.2026 |
| Guselkumab pensüstel 100mg | 20 000 € | 11.02.2026 |
| Guselkumab pensüstel 200mg | 20 000 € | 11.02.2026 |
| Guselkumab, infusioonilahuse kontsentraat | 20 000 € | 11.02.2026 |
Similar open tenders
- Parenteraalsed toitelahusedOpen for bidsDeadline 20.10.2026 3 daysEstimated value 400 000 €Published 18.09.2026
- KlesrovimabOpen for bidsDeadline 20.10.2026 3 daysEstimated value 190 000 €Published 05.10.2026
- Puhasruumide desinfektsiooni- ja puhastusvahendidOpen for bidsDeadline 21.10.2026 4 daysPublished 17.09.2026
- Urogenitaalsüsteemi ravimid ja hormoonravimidOpen for bidsDeadline 23.10.2026 6 daysPublished 18.09.2026
- Ravim B01AB05 EnoksapariinOpen for bidsDeadline 27.10.2026 10 daysPublished 21.09.2026
- Kemoteraapias kasutatavad ravimidOpen for bidsDeadline 27.10.2026 10 daysPublished 22.09.2026
Source: Public Procurement Register open data. Amounts exclude VAT. The notice published in the Public Procurement Register is binding.